Using an Information Package to Reduce Patients’ Risk of Renal Damage: Protocol for a Randomized Feasibility Trial

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are a common cause of renal damage, especially when taken together with angiotensin-converting enzyme inhibitors (ACE-i) or angiotensin II receptor blockers (ARBs) plus a diuretic — a combination known as the “triple whammy.” New Zealand pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Leitch, Sharon, Smith, Alesha, Zeng, Jiaxu, Stokes, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122288/
https://www.ncbi.nlm.nih.gov/pubmed/33929338
http://dx.doi.org/10.2196/29161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122288/
https://www.ncbi.nlm.nih.gov/pubmed/33929338
http://dx.doi.org/10.2196/29161

Ejemplares similares